NThe present application relates to novel substituted phenethyltriazoloneacetamides to processes for preparation thereof to the use thereof alone or in combinations for treatment and/or for prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases more particularly for treatment and/or prevention of cardiovascular disorders.